Determinations of the type and setting of empirical therapy for immunocompromised patients
with fever are complicated by the characteristics of the underlying illness and the effects of …

The oral and gastrointestinal mucosa acts as an important mechanical barrier that prevents
local or systemic invasion by microorganisms. Cytotoxic chemotherapy-induced mucosal …

Guidelines for preventing infectious complications among hematopoietic cell transplant
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …

Many of the identified points may have a great impact in the daily management of febrile
granulocytopenic patients. However, all recent epidemiological and therapeutical studies …

Background: The epidemiology of bacteremic febrile neutropenia differs between locations
and constitutes the basis for selection of empiric antibiotic therapy for febrile neutropenia …

Osteonecrosis of the jaw (ONJ) is a serious adverse event that occurs predominantly in
patients on both antiresorptive and antineoplastic therapies. However, how these …

OBJECTIVES: Previous studies from Lebanon have shown Gram-negative organisms to be
the predominant agents in febrile neutropenic patients. The objective of this study was to …

We studied 622 transplants undertaken between 1982 and 2001 to:(1) determine the
incidence, timing and etiology of bacteremias, and (2) examine the ability of routine …

Bacterial infections, particularly those due to gram-positive bacteria, continue to
predominate in patients with cancer. Coagulase-negative and coagulase-positive …

Hematopoietic progenitor cells from peripheral blood (HPCPB) are commonly used for
autologous and allogenic transplants in patients with most various onco-hematological …